Team:Goettingen/Team/Reporter
From 2013.igem.org
FMCommmichau (Talk | contribs) |
FMCommmichau (Talk | contribs) |
||
Line 40: | Line 40: | ||
===Reporter Team=== | ===Reporter Team=== | ||
<html> | <html> | ||
- | <p>The activity of transcriptional regulators can be easily detected by monitoring the activity of a promoter that is fused to a reporter gene. Recently, in <i>Mycobacterium smegmatis</i>, the transcriptional repressor DarR was identified (Zhang <i>et al.</i> 2013). DarR is capable of binding to a specific DNA sequence upon association with c-di-AMP. This led us to the idea of developing a powerful screening system to facilitate the identification of potential drugs interfering with c-di-AMP biofunction. While many Gram-positive bacteria (also pathogenic bacteria causing severe human diseases) require c-di-AMP for their growth, this molecule is not synthesized by the Gram-negative bacterium <i>Escherichia coli</i>. Thus, we intend to build a reporter system that is composed of existing and of novel biobricks that will be developed during the project (Figure 1). As <i>E. coli</i> does not require c-di-AMP for growth the screening system can be used to sort out those molecules from a drug library that interfere with general cellular processes (i.e. replication). By contrast, the system is suitable to identify compounds that specifically interfere with the signaling function of c-di-AMP. </p> | + | <p>The activity of transcriptional regulators can be easily detected by monitoring the activity of a promoter that is fused to a reporter gene such as the green fluorescent protein (GFP). Recently, in <i>Mycobacterium smegmatis</i>, the transcriptional repressor DarR was identified (Zhang <i>et al.</i> 2013). DarR is capable of binding to a specific DNA sequence upon association with c-di-AMP. This led us to the idea of developing a powerful screening system to facilitate the identification of potential drugs interfering with c-di-AMP biofunction. While many Gram-positive bacteria (also pathogenic bacteria causing severe human diseases) require c-di-AMP for their growth, this molecule is not synthesized by the Gram-negative bacterium <i>Escherichia coli</i>. Thus, we intend to build a reporter system that is composed of existing and of novel biobricks that will be developed during the project (Figure 1). As <i>E. coli</i> does not require c-di-AMP for growth the screening system can be used to sort out those molecules from a drug library that interfere with general cellular processes (i.e. replication). By contrast, the system is suitable to identify compounds that specifically interfere with the signaling function of c-di-AMP. </p> |
<div style="display:inline-block;background:#fff" class="prev half" > | <div style="display:inline-block;background:#fff" class="prev half" > |
Revision as of 19:35, 29 September 2013